EGFR and head and neck neoplasm: They can transactivate the epidermal growth factor receptor (EGFR), a biomarker that is virtually upregulated in all head and neck tumors, inducing the expression of several proteins, including COX 2, matrix metalloproteinases 2 and 9 and vascular endothelial growth factor [68].